Foster, Paul A. External Entity

Publications

Sort by

Selected publications

  • A phase 1 dose-escalation study of XmAb® 2513 in patients with relapsed or refractory Hodgkin lymphoma.  British journal of haematology2015 Academic Article GET IT
    Times cited: 5

Other